Protein Kinase B Alpha (PKBa)

[Edit]

AKT1; AKT; PKB-A; Proto-oncogene c-Akt; RAC-Alpha Serine/Threonine-Protein Kinase; V-akt Murine Thymoma Viral Oncogene Homolog 1

Protein Kinase B Alpha (PKBa)
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase.
In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC231Hu01 Recombinant Protein Kinase B Alpha (PKBa) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAC231Hu01 Polyclonal Antibody to Protein Kinase B Alpha (PKBa) WB; IHC; ICC; IP.
MAC231Hu21 Monoclonal Antibody to Protein Kinase B Alpha (PKBa) WB; IHC; ICC; IP.
Assay Kits SEC231Hu ELISA Kit for Protein Kinase B Alpha (PKBa) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPC231Mu01 Recombinant Protein Kinase B Alpha (PKBa) Positive Control; Immunogen; SDS-PAGE; WB.
RPC231Mu02 Recombinant Protein Kinase B Alpha (PKBa) Positive Control; Immunogen; SDS-PAGE; WB.
MPC231Mu01 Phosphorylated Protein Kinase B Alpha (PKBa) n/a
Antibodies PAC231Mu01 Polyclonal Antibody to Protein Kinase B Alpha (PKBa) WB; IHC; ICC; IP.
PAC231Mu02 Polyclonal Antibody to Protein Kinase B Alpha (PKBa) WB; IHC; ICC; IP.
AAC231Mu01 Anti-Phosphorylated Protein Kinase B Alpha (PKBa) Polyclonal Antibody WB.
AAC231Mu02 Anti-Phosphorylated Protein Kinase B Alpha (PKBa) Monoclonal Antibody WB.
Assay Kits SEC231Mu ELISA Kit for Protein Kinase B Alpha (PKBa) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Protein Kinase B Alpha (PKBa) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Protein Kinase B Alpha (PKBa) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Protein Kinase B Alpha (PKBa) Polyclonal Antibody Customized Service Offer
Assay Kits SEC231Ra ELISA Kit for Protein Kinase B Alpha (PKBa) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily."Proc. Natl. Acad. Sci. U.S.A. 88:4171-4175(1991) [PubMed] [Europe PMC] [Abstract]
  2. "Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes."Diabetologia 44:910-913(2001) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Human protein factory for converting the transcriptome into an in vitro-expressed proteome." Nat. Methods 5:1011-1017(2008) [PubMed] [Europe PMC] [Abstract]
  5. "The DNA sequence and analysis of human chromosome 14." Nature 421:601-607(2003) [PubMed] [Europe PMC] [Abstract]
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  7. "Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families."Eur. J. Biochem. 201:475-481(1991) [PubMed] [Europe PMC] [Abstract]
  8. ErratumEur. J. Biochem. 205:1217-1218(1992) [PubMed] [Europe PMC] [Abstract]
  9. "CREB is a regulatory target for the protein kinase Akt/PKB."J. Biol. Chem. 273:32377-32379(1998) [PubMed] [Europe PMC] [Abstract]
  10. "Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase."Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998) [PubMed] [Europe PMC] [Abstract]
  11. "Mechanism of activation of protein kinase B by insulin and IGF-1."EMBO J. 15:6541-6551(1996) [PubMed] [Europe PMC] [Abstract]
  12. "Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha."Biochem. J. 331:299-308(1998) [PubMed] [Europe PMC] [Abstract]
  13. "Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B."J. Biol. Chem. 274:17179-17183(1999) [PubMed] [Europe PMC] [Abstract]
  14. "Phosphorylation and regulation of Raf by Akt (protein kinase B)."Science 286:1741-1744(1999) [PubMed] [Europe PMC] [Abstract]
  15. "Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage."J. Biol. Chem. 275:34451-34458(2000) [PubMed] [Europe PMC] [Abstract]
  16. "The protooncogene TCL1 is an Akt kinase coactivator."Mol. Cell 6:395-407(2000) [PubMed] [Europe PMC] [Abstract]
  17. "Tcl1 enhances Akt kinase activity and mediates its nuclear translocation."Proc. Natl. Acad. Sci. U.S.A. 97:3028-3033(2000) [PubMed] [Europe PMC] [Abstract]
  18. "Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1."Mol. Cell. Biol. 21:893-901(2001) [PubMed] [Europe PMC] [Abstract]
  19. "Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane."Science 294:374-380(2001) [PubMed] [Europe PMC] [Abstract]
  20. "A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain."J. Biol. Chem. 277:22115-22118(2002) [PubMed] [Europe PMC] [Abstract]
  21. "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization."J. Biol. Chem. 277:28706-28713(2002) [PubMed] [Europe PMC] [Abstract]
  22. "Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase."J. Biol. Chem. 277:38021-38028(2002) [PubMed] [Europe PMC] [Abstract]
  23. "Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway."Mol. Cell 10:151-162(2002) [PubMed] [Europe PMC] [Abstract]
  24. "Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1."Mol. Cell. Biol. 22:1513-1525(2002) [PubMed] [Europe PMC] [Abstract]
  25. "PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization."Nat. Med. 8:1145-1152(2002) [PubMed] [Europe PMC] [Abstract]
  26. "Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk."Exp. Cell Res. 288:110-118(2003) [PubMed] [Europe PMC] [Abstract]
  27. "PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion."J. Biol. Chem. 279:16441-16451(2004) [PubMed] [Europe PMC] [Abstract]
  28. "LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway."J. Biol. Chem. 279:23151-23157(2004) [PubMed] [Europe PMC] [Abstract]
  29. ErratumJ. Biol. Chem. 282:2752-2752(2007)
  30. "Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt."Mol. Cell. Biol. 24:1493-1504(2004) [PubMed] [Europe PMC] [Abstract]
  31. "PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt."Proc. Natl. Acad. Sci. U.S.A. 101:6993-6998(2004) [PubMed] [Europe PMC] [Abstract]
  32. "Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation."Cancer Res. 65:9643-9650(2005) [PubMed] [Europe PMC] [Abstract]
  33. "Akt/PKB regulates actin organization and cell motility via Girdin/APE."Dev. Cell 9:389-402(2005) [PubMed] [Europe PMC] [Abstract]
  34. "Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex."Science 307:1098-1101(2005) [PubMed] [Europe PMC] [Abstract]
  35. "Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias."Acta Neuropathol. 112:715-725(2006) [PubMed] [Europe PMC] [Abstract]
  36. "Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha."Biochem. J. 395:653-662(2006) [PubMed] [Europe PMC] [Abstract]
  37. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  38. "Kinetic mechanism of AKT/PKB enzyme family."J. Biol. Chem. 281:13949-13956(2006) [PubMed] [Europe PMC] [Abstract]
  39. "Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding."Mol. Cell. Biol. 26:8267-8280(2006) [PubMed] [Europe PMC] [Abstract]
  40. "The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1."EMBO J. 26:4523-4534(2007) [PubMed] [Europe PMC] [Abstract]
  41. "Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation."J. Biol. Chem. 282:30836-30844(2007) [PubMed] [Europe PMC] [Abstract]
  42. "Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells."Anticancer Res. 28:957-963(2008) [PubMed] [Europe PMC] [Abstract]
  43. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  44. "The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt."Dev. Cell 17:800-810(2009) [PubMed] [Europe PMC] [Abstract]
  45. "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons."J. Biol. Chem. 284:24512-24525(2009) [PubMed] [Europe PMC] [Abstract]
  46. "The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration."J. Cell Sci. 122:4535-4546(2009) [PubMed] [Europe PMC] [Abstract]
  47. "The E3 ligase TRAF6 regulates Akt ubiquitination and activation."Science 325:1134-1138(2009) [PubMed] [Europe PMC] [Abstract]
  48. "Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt."Cancer Res. 70:1195-1203(2010) [PubMed] [Europe PMC] [Abstract]
  49. "Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120."J. Biol. Chem. 285:3815-3824(2010) [PubMed] [Europe PMC] [Abstract]
  50. "Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls cell survival after ionizing radiation."J. Biol. Chem. 285:31157-31163(2010) [PubMed] [Europe PMC] [Abstract]
  51. "The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration."Mol. Cell 38:333-344(2010) [PubMed] [Europe PMC] [Abstract]
  52. "Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway."PLoS ONE 5:E9616-E9616(2010) [PubMed] [Europe PMC] [Abstract]
  53. "Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation."PLoS ONE 5:E9646-E9646(2010) [PubMed] [Europe PMC] [Abstract]
  54. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  55. "Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2."Eur. J. Cell Biol. 90:420-431(2011) [PubMed] [Europe PMC] [Abstract]
  56. "Clk2 and B56-beta mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt."Mol. Cell 41:471-479(2011) [PubMed] [Europe PMC] [Abstract]
  57. "Signal transduction via the stem cell factor receptor/c-Kit."Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed] [Europe PMC] [Abstract]
  58. "The protein kinase B/Akt signalling pathway in human malignancy."Cell. Signal. 14:381-395(2002) [PubMed] [Europe PMC] [Abstract]
  59. "A novel human dynactin-associated protein, dynAP, promotes activation of Akt, and ergosterol-related compounds induce dynAP-dependent apoptosis of human cancer cells."Mol. Cancer Ther. 9:2934-2942(2010) [PubMed] [Europe PMC] [Abstract]
  60. "Akt signalling in health and disease."Cell. Signal. 23:1515-1527(2011) [PubMed] [Europe PMC] [Abstract]
  61. "Akt1 and Akt2: differentiating the aktion."Histol. Histopathol. 26:651-662(2011) [PubMed] [Europe PMC] [Abstract]
  62. "IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 108:6474-6479(2011) [PubMed] [Europe PMC] [Abstract]
  63. "The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy."Sci. Signal. 4:RA46-RA46(2011) [PubMed] [Europe PMC] [Abstract]
  64. "Akt is negatively regulated by the MULAN E3 ligase."Cell Res. 22:873-885(2012) [PubMed] [Europe PMC] [Abstract]
  65. "Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling."PLoS ONE 7:E37427-E37427(2012) [PubMed] [Europe PMC] [Abstract]
  66. "CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site."PLoS ONE 8:E65679-E65679(2013) [PubMed] [Europe PMC] [Abstract]
  67. "MOZ increases p53 acetylation and premature senescence through its complex formation with PML."Proc. Natl. Acad. Sci. U.S.A. 110:3895-3900(2013) [PubMed] [Europe PMC] [Abstract]
  68. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  69. "KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer."Neoplasia 16:247-256(2014) [PubMed] [Europe PMC] [Abstract]
  70. "High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate."Curr. Biol. 12:1256-1262(2002) [PubMed] [Europe PMC] [Abstract]
  71. "Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change."Biochem. J. 375:531-538(2003) [PubMed] [Europe PMC] [Abstract]
  72. "Synthesis and structure based optimization of novel Akt inhibitors."Bioorg. Med. Chem. Lett. 18:3359-3363(2008) [PubMed] [Europe PMC] [Abstract]
  73. "Discovery of pyrrolopyrimidine inhibitors of Akt."Bioorg. Med. Chem. Lett. 20:5607-5612(2010) [PubMed] [Europe PMC] [Abstract]
  74. "Design of selective, ATP-competitive inhibitors of Akt." J. Med. Chem. 53:4615-4622(2010) [PubMed] [Europe PMC] [Abstract]
  75. "Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition."PLoS ONE 5:E12913-E12913(2010) [PubMed] [Europe PMC] [Abstract]
  76. "Discovery and SAR of spirochromane Akt inhibitors."Bioorg. Med. Chem. Lett. 21:2410-2414(2011) [PubMed] [Europe PMC] [Abstract]
  77. "A transforming mutation in the pleckstrin homology domain of AKT1 in cancer." Nature 448:439-444(2007) [PubMed] [Europe PMC] [Abstract]
  78. "Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain."Biochemistry 47:12260-12269(2008) [PubMed] [Europe PMC] [Abstract]
  79. "A mosaic activating mutation in AKT1 associated with the Proteus syndrome." N. Engl. J. Med. 365:611-619(2011) [PubMed] [Europe PMC] [Abstract]
  80. "Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes."Am. J. Hum. Genet. 92:76-80(2013) [PubMed] [Europe PMC] [Abstract]